Pristyn Care, one of India’s prominent health-tech companies focusing on secondary care surgeries, is reportedly in discussions to secure USD 100 million in fresh funding. The company plans to channel these funds into expansion, technology upgrades, and operational enhancements to improve patient experiences.
Launched in 2018 by Harsimarbir Singh, Dr. Vaibhav Kapoor, and Dr. Garima Sawhney, Pristyn Care has carved a niche in India’s healthcare sector. Today, it operates across 30 cities, supported by a network of over 200 hospitals and 150 clinics, with a team of more than 400 in-house surgeons.
The funding efforts reflect Pristyn Care’s aggressive roadmap toward profitability, with sights set on an IPO in 2028. Key priorities for the expansion plan include deeper penetration into Tier 2 and Tier 3 cities, where access to specialized surgical care remains limited.
Pristyn Care – Financial Growth and Profitability Goals
Financially, Pristyn Care has been on a steady climb. In the fiscal year 2023-24, the company racked up a consolidated revenue of INR 632 crore, up by 28% from last year. Pristyn Care’s surgery segment saw a significant drop in EBITDA burn by 42%, thanks to more patients coming in naturally and less spending on marketing.
Looking ahead, the company is targeting a 35% revenue hike in 2024-25 while aiming to slash EBITDA burn by over 60%. This all ties into a bigger plan to hit profitability by FY 2026.
Co-founder Harsimarbir Singh put it like this: “Our numbers show we’re trusted by our patients, and we’re all about changing how healthcare is delivered through smart and efficient means.”
Innovation and Strategic Partnerships
Much of Pristyn Care’s recent success can be traced back to smart partnerships with insurance companies, which have made treatments more accessible through cashless claims and EMI options. The company has been piloting a cashless treatment program since October 2024, extending it even to hospitals not in their network. And their 45-minute Express Discharge Service is a game-changer for post-surgery patient flow.
These moves are in sync with India’s healthcare vision, especially the IRDAI’s ambitious ‘Insurance for All by 2047’ plan. For patients, this means fewer bureaucratic hoops and quicker claim processing, making healthcare more reachable and affordable.
Tech-wise, the company is investing in cutting-edge surgical tools and diagnostics that not only speed up recovery but also bolster its reputation for top-notch care.
Expansion Moves
On the international front, Pristyn Care expanded to Bangladesh in 2022—its first venture outside India. This move hints at bigger global aspirations, with the company reportedly scouting markets in Southeast Asia and the Middle East.
Domestically, Tier 2 and Tier 3 cities remain central to Pristyn Care’s plans. With advanced surgical care still out of reach for many in these areas, the company sees an opportunity to fill critical gaps.
Investor Confidence and Valuation Peaks
Pristyn Care hit unicorn status in 2021 with a USD 96 million Series E round, nudging its valuation to USD 1.4 billion. Investors like Tiger Global, Peak XV Partners, Epiq Capital, and Hummingbird Ventures are clearly on board with their vision.
The upcoming funding round, expected to wrap up by mid-2025, could see both old and new investors, including high-net-worth individuals and global funds, pouring in money. This cash would help scale operations, introduce AI-driven diagnostics, and push forward treatment technologies.
Pristyn Care’s IPO Ambitions and Future Outlook
With an IPO set for 2028, Pristyn Care’s game plan involves enhancing operational efficiencies, cutting costs, and deepening insurance ties. The company is focusing on tech like AI diagnostics, telemedicine, and robotic surgeries to cement its position as a healthcare innovator.
In the long haul, they see themselves reshaping how patients experience healthcare from diagnosis to post-surgery care. The IPO could be the springboard for broader global reach and pioneering innovations.
Final Thoughts
Pristyn Care’s bold expansion plans and patient-first approach highlight its ambition to Pristyn Care’s bold moves and patient-centric approach signal its intent to lead in India’s healthcare sector. With potentially USD 100 million on the way and IPO plans solidifying, the company is setting itself up as a key player to watch.
Their focus on making healthcare affordable, accessible, and tech-savvy bodes well for both investors and patients. As they scale up and look abroad, Pristyn Care might just redefine secondary care surgeries. Keep an eye out for how this unfolds as they chase profitability, global growth, and a revolution in modern healthcare. For more details related to IPO GMP, SEBI IPO Approval, and Live Subscription stay tuned to IPO Central.
